NICOLAS TORRES; MONTANA MANSELLE COCO; RAMIRO PERROTTA; YAMIL MAHMOUD ; MARIANA SALATINO; MARIÑO, KARINA V.; GABRIEL A RABINOVICH

A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins

Glycobiology; Año: 2023 vol. 33 p. 855 - 860

BANNOUD, NADIA; GARCÍA, P. ALFREDO; GAMBARTE-TUDELA, JULIAN; SUNDBLAD, VICTORIA; CAGNONI, ALEJANDRO J.; BACH, CAMILA A.; PÉREZ SAEZ, JUAN M.; BLIDNER, ADA G.; MALLER, SEBASTIÁN M.; MARIÑO, KARINA V.; SALATINO, MARIANA; CERLIANI, JUAN P.; RABINOVICH, GABRIEL A.; CROCI, DIEGO O.

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2022 vol. 2442 p. 635 - 653

CAGNONI A; GIRIBALDI ML; BLIDNER, A; CUTINE A; MORALES RM; GATTO S; SALATINO M; ABBA M; CROCI DO; MARIÑO KV; RABINOVICH GA

Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; Lugar: Washington DC, USA; Año: 2021

SEQUEIRA, GONZALO R.; SAHORES, ANA; DALOTTO-MORENO, TOMAS; PERROTTA, RAMIRO M.; PATACCINI, GABRIELA; VANZULLI, SILVIA I.; POLO, MARÍA L.; RADISKY, DEREK C.; SARTORIUS, CAROL A.; NOVARO, VIRGINIA; LAMB, CAROLINE A.; RABINOVICH, GABRIEL A.; SALATINO, MARIANA; LANARI, CLAUDIA

Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity

CANCER RESEARCH; Año: 2021 vol. 81 p. 1375 - 1387

PERROTTA RM; BACH C; SALATINO M; RAVINOVICH GA

Reprogramming the tumor metastasis cascade by targeting galectin-driven networks

The Biochemical journal; Año: 2021

GIROTTI, MARÍA ROMINA; SALATINO, MARIANA; DALOTTO-MORENO, TOMÁS; RABINOVICH, GABRIEL A.

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression

JOURNAL OF EXPERIMENTAL MEDICINE; Año: 2020 vol. 217

SALATINO, MARIANA; GIROTTI, MARÍA ROMINA; RABINOVICH, GABRIEL A.

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer

CANCER CELL; Año: 2018 vol. 33 p. 155 - 157

BLIDNER, A; SALATINO M; MASCANFRONI I; DIAMENT, M; BAL DE KIER JOFFé E; JASNIS MA; KLEIN. SA; RABINOVICH GA

Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments

JOURNAL OF IMMUNOLOGY; Lugar: Bethesda; Año: 2015 vol. 194 p. 3452 - 3462

SALATINO M; CROCI DO; LADERACH D.J.; COMPAGNO D; GENTILINI L; DERGAN-DYLON S; MENDEZ-HUERGO S; TOSCANO MA; CERLIANI JP; RABINOVICH GA

Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2015

CERLIANI JP; DALOTTO-MORENO T; COMPAGNO D; DERGAN-DYLON S; LADERACH D.J.; GENTILINI L; CROCI DO; MENDEZ-HUERGO S; TOSCANO MA; SALATINO M; RABINOVICH GA

Study of galectins in tumor immunity: strategies and methods

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2015 p. 249 - 268

SALATINO M; CROCI DO; LADERACH D.J.; COMPAGNO D; GENTILINI L; DERGAN-DYLON S; MENDEZ-HUERGO S; TOSCANO MA; CERLIANI JP; RABINOVICH GA

Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2015

BLIDNER, A; SALATINO M; MASCANFRONI I; DIAMENT, M; BAL DE KIER JOFFé E; JASNIS MA; KLEIN. SA; RABINOVICH GA

Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments

JOURNAL OF IMMUNOLOGY; Lugar: Bethesda; Año: 2015 vol. 194 p. 3452 - 3462

RUTKOWSKI MR; STEPHEN TL1; SVORONOS N; ALLEGREZZA MJ; TESONE AJ; PERALES-PUCHALT A; BRENCICOVA E; ESCOVAR-FADUL X; NGUYEN JM; ZHANG R; CADUNGOG MG; SALATINO M; TCHOU J; RABINOVICH GA; CONEJO-GARCIA JR

Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation

CANCER CELL; Lugar: United States; Año: 2015 vol. 27 p. 27 - 40

CERLIANI JP; DALOTTO-MORENO T; COMPAGNO D; DERGAN-DYLON S; LADERACH D.J.; GENTILINI L; CROCI DO; MENDEZ-HUERGO S; TOSCANO MA; SALATINO M; RABINOVICH GA

Study of galectins in tumor immunity: strategies and methods

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2015 p. 249 - 268

CROCI DO; CERLIANI JP; DALOTTO-MORENO T; MENDEZ-HUERGO S; MASCANFRONI I; DERGAN-DYLON S; TOSCANO MA; CARAMELO JJ; GARCíA-VALLEJO JJ; OUJANG J; MESRI EA; JUNTILLA MR; BAIS C; SHIPP M; SALATINO M; RABINOVICH GA

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.

CELL; Año: 2014 p. 744 - 758

CARLINI MJ; ROITMAN P; NUÑEZ ; PALLOTA G; BOGGIO ; SMITH; SALATINO M; BAL DE KIER JOFFÉ E; RABINOVICH GA; PURICELLI L

Clinical relevance of galectin-1 expression in non-small cell lung cancer patients

LUNG CANCER; Lugar: Amsterdam; Año: 2014 p. 73 - 78

DALOTTO-MORENO T; CROCI DO; CERLIANI JP; MARTINEZ ALLO V; DERGAN-DYLON S; MENDEZ-HUERGO S; STUPIRSKI JC; MAZAL D; OSINAGA E; TOSCANO MA; SUNDBLAD V; RABINOVICH GA; SALATINO M

Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease

CANCER RESEARCH; Lugar: Philadelphia; Año: 2013 p. 1107 - 1117

SALATINO M; DALOTTO-MORENO T; RABINOVICH GA

Thwarting galectin-induced immunosuppression in breast cancer.

Oncoimmunology; Año: 2013 vol. 1 p. 24077 - 24079

SPALLANZANI GR; DALOTTO-MORENO T; RAFFO IRAOLAGOITIA XL; ZIBLAT A; DOMAICA C; AVILA D; ROSSI L; FUERTES M; RABINOVICH GA; SALATINO M; ZWIRNER NW

Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2013 p. 1781 - 1785

CROCI DO; SALATINO M; RUBINSTEIN N; RABINOVICH GA

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi?s sarcoma

JOURNAL OF EXPERIMENTAL MEDICINE; Lugar: New York; Año: 2012 p. 1085 - 2000

SOLDATI R; BERGER E; ZENCLUSSEN AC; JORCH G; LODE HN; SALATINO M; RABINOVICH GA; FEST S

Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2012 p. 1131 - 1141

ZACARIAS FLUCK, M; HESS L; SALATINO M ; CROCI DO; STUPIRSKI JC; DI MASSO ; RABINOVICH GA; SCHAROVSKY GO

The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2012 p. 469 - 480

CRISTINA MALDONADO; VICTORIA SUNDBLAD; MARIANA SALATINO

Cell type specific regulation of galectin-3 expression by glucocorticoids in lung Clara cell and macrophages

HISTOLOGY AND HISTOPATHOLOGY; Año: 2011 vol. 26 p. 747 - 759

DIEGO O CROCI; MARIANA SALATINO

Tumor Immune Escape Mechanisms that Operate During Metastasis

CURRENT PHARMACEUTICAL BIOTECHNOLOGY; Año: 2011 p. 1923 - 1936

MARIANA SALATINO; GABRIEL A RABINOVICH

Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Lugar: 2011;677:355-74.; Año: 2011 vol. 677 p. 355 - 374

LADERACH D.J.; COMPAGNO D; TOSCANO MA; CROCI DO; DERGAN-DYLON S; SALATINO M; RABINOVICH GA

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.

IUBMB LIFE; Año: 2010 vol. 62 p. 1 - 13

SALATINO M; RABINOVICH GA

Fine-tuning antitumor responses through the control of galectin-glycan interactions

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2009

J. M. ILARREGUI; CROCI DO; BIANCO GA; TOSCANO MA; SALATINO M,; VERMEULEN M; GEFFNER J; RABINOVICH GA

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

NATURE IMMUNOLOGY (PRINT); Año: 2009 p. 981 - 991

RIVAS MA; CARNEVALE RP; PROIETTI CJ; ROSEMBLIT C; BEGUELIN W; SALATINO M; CHARREAU EH; FRAHM I; SAPIA S; BROUCKAERT P; ELIZALDE PV; SCHILLACI R

TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways

EXPERIMENTAL CELL RESEARCH; Año: 2008 p. 509 - 529

MARIANA SALATINO; , DIEGO O CROCI; GERMÁN A BIANCO; JUAN M ILARREGUI; MARTA A TOSCANO; GABRIEL A RABINOVICH

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

EXPERT OPINION ON BIOLOGICAL THERAPY; Año: 2008 p. 45 - 57

DAROQUI CM; IARREGUI JM; RUBINSTEIN N; SALATINO M; TOSCANO MA; VAZQUEZ P; BAKIN A; PURICELLI L; BAL DE KIER JOFFÉ E; RABINOVICH GA

Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.

CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2007 p. 491 - 499

CARNEVALE RP; PROIETTI CJ; SALATINO M; URTREGER A; PELUFFO G; EDWARDS DP; BOONYARATANAKORNKIT V; CHARREAU EH; BAL DE KIER JOFFÉ E; SCHILLACI R; ELIZALDE PV

Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.

MOLECULAR ENDOCRINOLOGY; Año: 2007 p. 1335 - 1358

TOSCANO MA; ILARREGUI JM; BIANCO GA; CAMPAGNA L; CROCI DO; SALATINO M,; RABINOVICH GA

Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?

CYTOKINE & GROWTH FACTOR REVIEWS; Año: 2007 p. 57 - 71

MARIANA SALATINO; WENDY BEGUELIN; MARIA GISELLE PETERS; ROMINA CARNEVALE; PROIETTI CECILIA JAZMIIN; MARIO GALIGNIANA

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.

ONCOGENE; Año: 2006 p. 7723 - 7739

MARIANA SALATINO, ROXANA SCHILLACI , JULIANA CASSATARO, CECILIA J. PROIETTI , GUILLERMO H. GIAMBARTOLOMEI, MARTÍN RIVAS, ROMINA CARNEVALE, EDUARDO H. CHARREAU , PATRICIA V. ELIZALDE

Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+-Response Involving Fas/Fas Ligand Cytotoxic Pathway

JOURNAL OF IMMUNOLOGY; Año: 2006 p. 3426 - 3437

PROIETTI C, SALATINO M, ROSEMBLIT C, CARNEVALE R, PECCI A, KORNBLIHTT AR, MOLINOLO AA, FRAHM I, CHARREAU EH, SCHILLACI R, ELIZALDE PV.

Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells

MOLECULAR AND CELLULAR BIOLOGY; Año: 2005 vol. 25 p. 4826 - 4840

SALATINO M, SCHILLACI R, PROIETTI CJ, CARNEVALE R, FRAHM I, MOLINOLO AA, IRIBARREN A, CHARREAU EH, ELIZALDE PV.

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor acti

ONCOGENE; Año: 2004 p. 5161 - 5174

SALATINO M, SCHILLACI R, PROIETTI CJ, CARNEVALE R, CHARREAU EH, ELIZALDE PV.

Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer

MEDICINA; Lugar: Buenos Aires; Año: 2004 p. 129 - 134

LABRIOLA L, SALATINO M, PROIETTI CJ, PECCI A, COSO OA, KORNBLIHTT AR, CHARREAU EH, ELIZALDE PV.

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells

MOLECULAR AND CELLULAR BIOLOGY; Año: 2003 vol. 23 p. 1095 - 1111

PURICELLI L, PROIETTI CJ, LABRIOLA L, SALATINO M, BALANA ME, AGUIRRE GHISO J, LUPU R, PIGNATARO OP, CHARREAU EH, BAL DE KIER JOFFE E, ELIZALDE PV.

Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2002 vol. 100 p. 642 - 653

BALANA ME, LABRIOLA L, SALATINO M, MOVSICHOFF F, PETERS G, CHARREAU EH, ELIZALDE PV.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.

ONCOGENE; Año: 2001 vol. 20 p. 34 - 47

BALANA ME, LABRIOLA L, SALATINO M, MOVSICHOFF F, PETERS G, CHARREAU EH, ELIZALDE PV.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.

ONCOGENE; Año: 2001 vol. 20 p. 34 - 47

SALATINO M, LABRIOLA L, SCHILLACI R, CHARREAU EH, ELIZALDE PV.

Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.

EXPERIMENTAL CELL RESEARCH; Año: 2001 p. 152 - 166

VIEGAS MH, SALATINO M, GOIN M, PETERS G, LABRIOLA L, COSTA DA CUNHA J, LANARI C, CHARREAU EH, ELIZALDE PV.

Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.

CANCER DETECTION AND PREVENTION; Año: 1999 p. 375 - 386